| 108 |
Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
BY-SA |
724: Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme
|
719: Increase, hepatocellular adenomas and carcinomas
|
|
|
| 58 |
NR1I3 (CAR) suppression leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
4 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 479 |
Mitochondrial complexes inhibition leading to left ventricular function decrease via increased myocardial oxidative stress |
Sivakumar Murugadoss |
BY-SA |
105: Inhibition, Mitochondrial Electron Transport Chain Complexes
|
2215: Decrease Left Ventricular function
|
Under Development |
1.102 |
| 480 |
Mitochondrial complexes inhibition leading to heart failure via decreased ATP production |
Alexandra Schaffert |
BY-SA |
105: Inhibition, Mitochondrial Electron Transport Chain Complexes
|
2215: Decrease Left Ventricular function
|
Under Development |
1.102 |
| 491 |
Decrease, GLI1/2 target gene expression leads to orofacial clefting |
Jacob Reynolds |
BY-SA |
2040: Decrease, GLI1/2 target gene expression
|
2042: Increase, Orofacial clefting
|
Under Development |
1.101 |
| 502 |
Decrease, cholesterol synthesis leads to orofacial clefting |
Jacob Reynolds |
BY-SA |
None
|
2042: Increase, Orofacial clefting
|
Under Development |
1.101 |
| 4 |
Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1 |
Knut Erik Tollefsen |
BY-SA |
103: Increase, Ecdysone receptor hyperactivation
|
2 AOs
|
|
|
| 28 |
Cyclooxygenase inhibition leading reproductive failure |
Dan Villeneuve |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
253: N/A, Reproductive failure
|
|
|
| 29 |
Estrogen receptor agonism leading to reproductive dysfunction |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
4 AOs
|
|
|
| 32 |
Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors |
Undefined |
BY-SA |
None
|
None
|
|
|
| 34 |
LXR activation leading to hepatic steatosis |
Undefined |
BY-SA |
2 MIEs
|
345: N/A, Liver Steatosis
|
|
|
| 36 |
Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis |
Michelle Angrish |
BY-SA |
3 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 52 |
ER agonism leading to skewed sex ratios due to altered sexual differentiation in males |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
417: skewed, sex ratio
|
|
|
| 53 |
ER agonism leading to reduced survival due to renal failure |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
None
|
|
|
| 57 |
AhR activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
18: Activation, AhR
|
459: Increase, Liver steatosis
|
|
|
| 73 |
Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity |
Undefined |
BY-SA |
526: Inhibition, Inhibition of Dopamine-beta-hydroxylase
|
527: Decreased, Decreased fecundity
|
|
|
| 59 |
HNF4alpha suppression leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
461: Suppression, HNF4alpha
|
None
|
|
|
| 60 |
NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
245: Activation, PXR/SXR
|
459: Increase, Liver steatosis
|
|
|
| 61 |
NFE2L2/FXR activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
2 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 62 |
AKT2 activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
486: systemic inflammation leading to hepatic steatosis
|
459: Increase, Liver steatosis
|
|
|
| 63 |
Cyclooxygenase inhibition leading to reproductive dysfunction |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 64 |
Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility |
Undefined |
BY-SA |
494: Glucocorticoid Receptor Agonist, Activation
|
406: decreased, Fertility
|
|
|
| 66 |
Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 67 |
Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 68 |
Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome |
Undefined |
BY-SA |
661: Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|